-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $700

Benzinga·10/07/2026 18:16:04
Diffusion vocale
Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $665 to $700.